TL;DR
This study investigates the prevalence and impact of malnutrition in Chinese children with solid tumors. It reveals that undernutrition is common and significantly associated with adverse clinical outcomes, including longer hospital stays, higher costs, and increased risk of complications like neutropenia and ICU transfers.
What Problem Does This Paper Address?
Childhood cancer survival rates have dramatically improved, but treatment and the tumors themselves can lead to significant adverse effects, including malnutrition. Malnutrition, defined as inadequate or excessive intake of nutrients, can manifest as undernutrition (stunting, wasting, underweight) or overnutrition (overweight/obesity). In pediatric cancer patients, undernutrition is a particular concern, affecting treatment tolerance, potentially leading to dose adjustments, treatment interruptions, and impacting quality of life. While malnutrition is recognized as a problem, there's a need for more research on its long-term trends and specific associations with clinical outcomes in diverse populations, particularly in China, where such studies are less common. This paper aims to fill this gap by examining nutritional status at diagnosis and over time, and its relationship with clinical outcomes in a Chinese cohort of children with solid tumors.
Methods
This was a retrospective cohort study analyzing medical records of children diagnosed with solid tumors at the Children's Hospital of Fudan University in China. Data was collected from January 2016 to December 2021 for patients followed for at least 3 months.
Key data points collected included:
- Demographics: Age, sex, nationality.
- Clinical Information: Diagnosis, pathology, tumor staging, metastasis, parenteral nutrition (PN) use, ICU transfers, infection during hospitalization, surgery, hospitalization costs, and antibiotic costs.
- Nutritional Status: Height, weight, BMI, and biochemical markers (total protein, albumin, prealbumin, retinol-binding protein). Nutritional status was categorized using World Health Organization (WHO) Z-score standards for height-for-age (H/A), weight-for-age (W/A), and BMI-for-age (BMI/A). Undernutrition was defined as Z-scores below -1 SD, with further classification into mild, moderate, and severe acute malnutrition. Overweight and obesity were defined as Z-scores greater than +2 and +3 SD, respectively.
Statistical analysis involved descriptive statistics (median, mean ± SD, frequencies, percentages) and inferential statistics such as Fisher's exact test, Chi-squared test, two-sample t-test, and Mann-Whitney U test to compare groups. Multilevel analyses and binary logistic regression were used to assess the relationship between nutritional status and clinical outcomes, adjusting for potential confounders.
Datasets
The study utilized a dataset of 764 pediatric patients with solid tumors from the Children's Hospital of Fudan University, Shanghai, China, with medical records spanning from January 2016 to December 2021. This dataset is not publicly available due to privacy and ethical restrictions.
Key Insights and Ideas
- Significant Undernutrition Burden: A substantial proportion of children with solid tumors were undernourished at diagnosis (26.71%), highlighting a critical issue in this population.
- Dynamic Nutritional Changes: Nutritional status wasn't static; BMI Z-scores fluctuated throughout treatment, showing an initial decrease followed by some improvement, but with overall significant variations depending on tumor type.
- Undernutrition as a Predictor of Adverse Outcomes: The study provides strong evidence that undernutrition is not just a symptom but a significant risk factor for poorer clinical outcomes.
- Cost Implications: The financial burden of treating undernourished children is considerably higher, encompassing both hospitalization and antibiotic costs.
- Specific Complication Risks: Undernourished children face a significantly increased risk of neutropenia and ICU transfers, underscoring the systemic impact of poor nutritional status.
Key Results
- Prevalence: At diagnosis, 26.71% of children were undernourished, and 5.21% were overweight or obese.
- Clinical Outcomes: Patients with undernutrition experienced:
- Longer median hospital stays (15 vs. 12 days, p<0.001).
- Higher total hospitalization costs (0.033 vs. 0.029 million yuan, p<0.001).
- Higher antibiotic costs (925.2 vs. 403.4 yuan, p<0.001).
- Increased risk of ICU transfers (univariate OR=1.498, p=0.044; multivariate OR=1.265, p=0.046).
- Higher risk of neutropenia (univariate OR=4.781, p=0.006; multivariate OR=4.781, p=0.006).
- Higher likelihood of receiving PN (univariate OR=2.878, p=0.005; multivariate OR=3.596, p=0.006).
- Tumor Type Variations: Neuroblastoma and hepatoblastoma were the most common solid tumors. Nutritional status varied by tumor type, with some showing initial deterioration and others gradual improvement or fluctuation.
Limitations and Future Work
The authors acknowledge several limitations:
- Retrospective Design: Reliance on existing medical records meant that not all anthropometric data (e.g., mid-upper arm circumference, MUAC) could be collected, which are considered sensitive indicators of nutritional status.
- Lack of Mortality Data: The study could not assess the impact of nutritional status on long-term outcomes like survival time, relapse, or quality of life, as all patients were alive at the last discharge.
- Limited Overweight/Obese Cohort: The small number of overweight or obese children prevented a thorough analysis of obesity's impact on clinical outcomes.
- Data Recording Variability: In some instances, weight and height data were not consistently recorded in electronic medical records, potentially hindering precise nutritional assessment.
Future work should focus on:
- Strengthening nutrition interventions and exploring a variety of tools for better nutritional assessment, including arm anthropometry and ultrasound.
- Conducting large-scale cohort studies with comprehensive data collection to address the impact of obesity and long-term clinical outcomes.
- Improving the standardization of nutritional diagnosis and treatment, including comprehensive screening and individualized guidance.
Summary updated